Gilead pays Nimbus $200M after fast progress in NASH
Home
Our Approach
Pipeline & Targets
→
← Back
/ Pipeline & Targets /
Pipeline & Targets Overview
Our Pipeline
Nimbus Programs
Acquired Programs
Publications & Presentations
News & Events
Culture & Careers
About Us
→
← Back
/ About Us /
About Us Overview
Nimbus Leadership
Board of Directors
Investors
Contact Us
Nimbus Therapeutics
< Back to News & Events
November 02, 2016
Gilead pays Nimbus $200M after fast progress in NASH